Seto T, Nakane S, Ji L, Ueda Y, et al. Real-world safety and effectiveness of entrectinib in Japanese patients with ROS1 gene fusion-positive, unresectable, advanced/recurrent non-small cell lung cancer: Post-marketing surveillance. Lung Cancer 2025;203:108478.
PMID: 40179540